CJC (WITH DAC) 5MG

CJC-1295 (WITH DAC) 5MG | LONG-ACTING GHRH ANALOG

CJC-1295 (With DAC) is a synthetic tetrasubstituted peptide analog of Growth Hormone Releasing Hormone (GHRH). By incorporating the Drug Affinity Complex (DAC), the peptide binds covalently to plasma albumin, providing a vastly extended half-life compared to standard GHRH analogs. This 5mg formulation is precision-engineered for long-term research models focusing on steady-state growth hormone (GH) elevation.

Key Research Mechanisms

• Albumin Binding: The DAC modification allows the peptide to utilize circulating albumin as a carrier, extending its biological activity to several days. This is a primary focus for research into non-pulsatile, continuous GH secretion.

• Sustained IGF-1 Production: Research centers on how consistent GH elevation from CJC-1295 (With DAC) leads to a stable and prolonged increase in Insulin-like Growth Factor 1 (IGF-1) levels.

• Metabolic Programming: It is utilized in studies observing the long-term effects of GH on lipid metabolism, specifically the reduction of adipose tissue through continuous lipolytic stimulation.

• Anabolic Modeling: Investigators use this compound to evaluate systemic protein synthesis and the long-term preservation of lean muscle mass in various physiological stress models.

Product Specifications

• Concentration: 5mg

• Form: Lyophilized Powder

• Purity: >99% (HPLC Verified)

• Storage: Store at -20°C for long-term stability. Protect from light and moisture. Once reconstituted, the compound remains stable at 2°C–8°C, though immediate use or limited storage is recommended for maximum integrity.

The LNGVIX Precision Protocol

The 5mg CJC-1295 (With DAC) is manufactured using high-fidelity conjugation techniques to ensure the DAC linker is properly positioned, guaranteeing the expected pharmacokinetic profile for longitudinal laboratory studies.

LABORATORY PRECAUTION: This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic use. All research protocols must be executed by qualified laboratory professionals.